Phenazopyridine for Confirmation of Ureteral Patency

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Cystoscopy
Interventions
DRUG

Phenazopyridine

Trial Locations (1)

06106

Hartford Hospital, Hartford

All Listed Sponsors
lead

Hartford Hospital

OTHER

NCT02424149 - Phenazopyridine for Confirmation of Ureteral Patency | Biotech Hunter | Biotech Hunter